Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Yang Ng

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Aging Cell|February 15, 2025
Exploring Lymph Node Stroma Ageing: Immune Implications and Future DirectionsYu Yang Ng, Andy Tay
Molecular Therapy. Methods & Clinical Development|December 2, 2021
piggyBac system to co-express NKG2D CAR and IL-15 to augment the <i>in vivo</i> persistence and anti-AML activity of human peripheral blood NK cellsZhicheng Du, Yu Yang Ng, Shijun Zha, et al.
Molecular Therapy Oncolytics|January 24, 2020
CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal XenograftsYu Yang Ng, Johan C K Tay, Shu Wang
Cancer Gene Therapy|September 2, 2021
CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse modelYu Yang Ng, Zhicheng Du, Xi Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2020
T Cells Expressing NKG2D CAR with a DAP12 Signaling Domain Stimulate Lower Cytokine Production While Effective in Tumor EradicationYu-Yang Ng, Johan C K Tay, Zhendong Li, et al.
Journal of Cancer Research and Clinical Oncology|June 3, 2023
T cells with split CARs specific for NKG2D ligands and PD-L1 exhibit improved selectivity towards monocyte-derived cells while effective in eliminating acute myeloid leukaemia in vivoLu Sun, Guangyi Jiang, Yu Yang Ng, et al.
Cancer Immunology, Immunotherapy : CII|July 9, 2022
Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasisGuangyi Jiang, Yu Yang Ng, Johan C K Tay, et al.
Plos One|June 16, 2022
Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growthXi Zhang, Yu Yang Ng, Zhicheng Du, et al.
Immunotherapy|June 24, 2020
Experimental treatment of colorectal cancer in mice with human T cells electroporated with NKG2D RNA CARZhendong Li, Zhixia Chi, Wei-Xia Ang, et al.
Immunotherapy|February 14, 2022
A CD123-specific chimeric antigen receptor augments anti-acute myeloid leukemia activity of Vγ9Vδ2 T cellsXi Zhang, Wei Xia Ang, Zhicheng Du, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Aging Cell|February 15, 2025
Exploring Lymph Node Stroma Ageing: Immune Implications and Future DirectionsYu Yang Ng, Andy Tay
Molecular Therapy. Methods & Clinical Development|December 2, 2021
piggyBac system to co-express NKG2D CAR and IL-15 to augment the <i>in vivo</i> persistence and anti-AML activity of human peripheral blood NK cellsZhicheng Du, Yu Yang Ng, Shijun Zha, et al.
Molecular Therapy Oncolytics|January 24, 2020
CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal XenograftsYu Yang Ng, Johan C K Tay, Shu Wang
Cancer Gene Therapy|September 2, 2021
CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse modelYu Yang Ng, Zhicheng Du, Xi Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2020
T Cells Expressing NKG2D CAR with a DAP12 Signaling Domain Stimulate Lower Cytokine Production While Effective in Tumor EradicationYu-Yang Ng, Johan C K Tay, Zhendong Li, et al.
Journal of Cancer Research and Clinical Oncology|June 3, 2023
T cells with split CARs specific for NKG2D ligands and PD-L1 exhibit improved selectivity towards monocyte-derived cells while effective in eliminating acute myeloid leukaemia in vivoLu Sun, Guangyi Jiang, Yu Yang Ng, et al.
Cancer Immunology, Immunotherapy : CII|July 9, 2022
Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasisGuangyi Jiang, Yu Yang Ng, Johan C K Tay, et al.
Plos One|June 16, 2022
Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growthXi Zhang, Yu Yang Ng, Zhicheng Du, et al.
Immunotherapy|June 24, 2020
Experimental treatment of colorectal cancer in mice with human T cells electroporated with NKG2D RNA CARZhendong Li, Zhixia Chi, Wei-Xia Ang, et al.
Immunotherapy|February 14, 2022
A CD123-specific chimeric antigen receptor augments anti-acute myeloid leukemia activity of Vγ9Vδ2 T cellsXi Zhang, Wei Xia Ang, Zhicheng Du, et al.
Pageof 2